<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7691145</article-id><article-id pub-id-type="pmc">1968625</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Uchida</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wada</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shitara</surname><given-names>T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Egawa</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Koshiba</surname><given-names>K.</given-names></name></contrib></contrib-group><aff>Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan.</aff><pub-date pub-type="ppub"><month>10</month><year>1993</year></pub-date><volume>68</volume><issue>4</issue><fpage>751</fpage><lpage>755</lpage><abstract><p>A study was made of the incidence of p53 mutations in Japanese males with prostate cancer or benign prostatic hyperplasia. Polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) was used as a primary screening technique with gene sequencing being carried out in positive cases. Two out of 21 prostate cancers (9.5%) were found to have p53 mutations. These were stage B2 and D2 prostate cancers. No abnormalities were found in the remaining cases or benign prostatic hyperplasia. Mutations of the p53 gene would thus appear infrequent in the tumourigenesis of primary prostate cancer.</p><sec sec-type="scanned-figures"><title>Images</title><fig id="F1"><label>Figure 1</label><graphic xlink:href="brjcancer00200-0108-a" xlink:role="752"/></fig><fig id="F2"><label>Figure 2</label><graphic xlink:href="brjcancer00200-0109-a" xlink:role="753"/></fig><fig id="F3"><label>Figure 3</label><graphic xlink:href="brjcancer00200-0110-a" xlink:role="754"/></fig></sec></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00200-0107.tif" xlink:title="scanned-page" xlink:role="751" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00200-0108.tif" xlink:title="scanned-page" xlink:role="752" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00200-0109.tif" xlink:title="scanned-page" xlink:role="753" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00200-0110.tif" xlink:title="scanned-page" xlink:role="754" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00200-0111.tif" xlink:title="scanned-page" xlink:role="755" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

